An important priority in the cardiovascular care of oncology patients is to reduce morbidity
and mortality, and improve the quality of life in cancer survivors through cross-disciplinary …

Innovative therapeutic strategies in childhood cancer led to a significant reduction in cancer-
related mortality. Cancer survivors are a growing fragile population, at risk of long-term side …

Introduction Chemotherapy has significantly improved cancer survival rates at the cost of
irreversible and frequent cardiovascular toxicity. As the main dose-dependent adverse …

Simple Summary The application of immunotherapies to treat cancer patients has
significantly improved over the last two decades and extended many patients' life spans …

Pediatric cancer survivors may experience cardiometabolic sequelae over the course of
their lives as a result of the treatments they have received. While nutrition consists of an …

Background Treatment-induced cardiotoxicity is a leading noncancer-related cause of acute
and late onset morbidity and mortality in cancer patients on antineoplastic drugs such as …

Childhood and adolescent cancer survivors are disproportionately more likely to develop
cardiovascular diseases from the late effects of cardiotoxic therapies (eg, anthracycline …

The landscape of pediatric oncology has dramatically changed over the course of the past
several decades with five-year survival rates surpassing 80%. Anthracycline therapy has …

SciELO - Brasil - Posicionamento sobre Indicações da Ecocardiografia em Cardiologia Fetal,
Pediátrica e Cardiopatias Congênitas do Adulto – 2020 Posicionamento sobre Indicações da …

Background We aim to establish the characteristics of published cardio‐oncology research
of clinical trials by bibliometric analysis and to talk about the prospects and difficulties facing …